Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AUA 2022 | MRI-targeted biopsies and overdiagnosis in prostate cancer

Andrew Vickers, PhD, Memorial Sloan Kettering Cancer Center, New York City, NY, compares the use of MRI-targeted biopsies to systematic biopsies for detecting high-grade prostate cancer and discusses how to tackle the risk of over-treatment and overdiagnosis. Dr Vickers also explains the possible uses of MRI in prostate cancer treatment and diagnosis, as well as discussing a variety of recent studies which have shown the benefit of doing an MRI targeted biopsy rather than a systematic biopsy to detect high-grade cancers. This interview took place at the American Urological Association annual congress 2022 in New Orleans and online.

Disclosures

I receive royalties from sale of the 4Kscore, a prostate cancer test

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.